Researchers at Keck Medicine, University of Southern California (USC) have discovered that combining immunotherapy with laser heat therapy could significantly extend the survival of individuals diagnosed with deadly brain cancers, according to a recent press release.
The study, which focused on patients with glioblastoma and other aggressive brain tumors, demonstrated that the combination therapy improved outcomes compared to standard treatments alone. The laser heat therapy, known as laser interstitial thermal therapy (LITT), is a minimally invasive procedure that uses heat to destroy tumor cells. When combined with immunotherapy drugs that help the immune system recognize and attack cancer, the treatment appears to enhance the body's natural defenses against the tumor.
This approach is particularly important because brain tumors like glioblastoma have a poor prognosis, with median survival often less than 15 months despite aggressive treatment. The new combination could offer a much-needed option for patients who have limited alternatives.
The research highlights the potential of combining local tumor destruction with systemic immune activation. By using LITT to kill cancer cells, the treatment may also release tumor antigens that prime the immune system to target remaining cancer cells throughout the brain. Immunotherapy then amplifies this response, potentially leading to longer-lasting effects.
Entities like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are engaged in developing treatments for brain cancers, though this study was conducted independently at USC. The findings add to a growing body of evidence that combination therapies may be key to improving outcomes in hard-to-treat cancers.
For more details on the study, visit the original source at BioMedWire. The full terms of use and disclaimers are available on the BioMedWire website.
This breakthrough underscores the importance of continued research into innovative treatment combinations for brain cancer, offering hope to patients and their families facing these devastating diagnoses.
